Man Group’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$931K	Buy	+339,775	New	+$1.08M	﹤0.01%	1862
2024 Q4	–	Sell	-25,692	Closed	-$42.4K	–	2045
2024 Q3	$42.4K	Buy	+25,692	New	+$51.9K	﹤0.01%	1925
2024 Q2	–	Sell	-440,770	Closed	-$1.18M	–	2089
2024 Q1	$1.18M	Buy	440,770 +223,785	+103%	+$544K	﹤0.01%	1488
2023 Q4	$649K	Buy	+216,985	New	+$281K	﹤0.01%	1588
2023 Q3	–	Sell	-117,251	Closed	-$170K	–	1866
2023 Q2	$163K	Buy	+117,251	New	+$164K	﹤0.01%	1845
2023 Q1	–	Sell	-18,100	Closed	-$93.4K	–	1948
2022 Q4	$113K	Buy	+18,100	New	+$129K	﹤0.01%	1891
2022 Q2	–	Sell	-112,903	Closed	-$640K	–	1724
2022 Q1	$524K	Buy	+112,903	New	+$484K	﹤0.01%	1569
2021 Q4	–	Sell	-15,756	Closed	-$190K	–	1998
2021 Q3	$190K	Buy	15,756 +1,978	+14%	+$28.8K	﹤0.01%	1768
2021 Q2	$291K	Sell	13,778 -14,248	-51%	-$343K	﹤0.01%	1683
2021 Q1	$786K	Sell	28,026 -9,554	-25%	-$282K	﹤0.01%	1356
2020 Q4	$977K	Buy	37,580 +19,969	+113%	+$598K	﹤0.01%	1419
2020 Q3	$655K	Buy	17,611 +281	+2%	+$11.1K	﹤0.01%	1484
2020 Q2	$889K	Buy	17,330 +10,992	+173%	+$460K	﹤0.01%	1309
2020 Q1	$200K	Sell	6,338 -276,658	-98%	-$14.6M	﹤0.01%	1470
2019 Q4	$16.9M	Buy	282,996 +76,369	+37%	+$3.43M	0.06%	419
2019 Q3	$7.58M	Sell	206,627 -52,056	-20%	-$2.06M	0.03%	685
2019 Q2	$12M	Buy	258,683 +24,566	+10%	+$1.15M	0.04%	544
2019 Q1	$9.4M	Buy	234,117 +70,331	+43%	+$3.15M	0.04%	603
2018 Q4	$7.54M	Buy	163,786 +20,218	+14%	+$974K	0.03%	571
2018 Q3	$6.37M	Buy	143,568 +120,357	+519%	+$5.53M	0.02%	859
2018 Q2	$910K	Buy	+23,211	New	+$1.17M	﹤0.01%	1631